Arctic Bioscience AS

Arctic Bioscience AS P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Arctic Bioscience AS (ABS.OL) as of Oct 16, 2026 is -3.97. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -1.99 — a change of 100.23% (lower).

P/CF

-3.97

YoY

100.23%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Arctic Bioscience AS is 2025 -3.97 . P/CF (Price-to-Cash-Flow Ratio) of Arctic Bioscience AS was 2024 -1.99 . It decreases by 100.23% lower compared to the previous year.

The Arctic Bioscience AS P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2019
41.69 NOK
Jan 1, 2020
-4.11 NOK
Jan 1, 2021
-2.28 NOK
Jan 1, 2022
-3.55 NOK
Jan 1, 2023
-2.23 NOK
Jan 1, 2024
-1.99 NOK
Jan 1, 2025
-3.97 NOK
The Arctic Bioscience AS P/CF history
YEARP/CFYoY
-3.97+100.23%
-1.99-11.18%
-2.23-36.96%
-3.55+55.51%
-2.28-44.57%
-4.11-109.87%
41.69—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Arctic Bioscience AS Stock analysis

What does Arctic Bioscience AS do? Arctic Bioscience AS is a biotechnology company headquartered in Orsta, Norway, operating within the Health Care sector. The company focuses on the development, manufacturing, and marketing of marine ingredients derived from herring roe. It completed its initial public offering (IPO) on February 24, 2021. Arctic Bioscience aims to provide effective and healthy therapeutic solutions for individuals with autoimmune disorders through marine membrane lipids. The company is developing HRO350, an investigational drug candidate intended for the treatment of mild-to-moderate psoriasis. Its product portfolio includes Romega, a dietary supplement containing omega-3 fatty acids sourced from herring roe in capsule form, as well as herring caviar oil and herring caviar protein offered to business customers. The company operates through three subsidiaries: Arctic Nutrition AS, Romega AS, and Arctic Biopharma AS. Arctic Bioscience AS is listed on the Oslo Stock Exchange under the ticker symbol ABS.OL and holds the ISIN NO0010859580. The company's activities are centered around leveraging marine resources for health-related applications, with a focus on innovative biotechnology solutions for autoimmune conditions and skin health. Arctic Bioscience AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arctic Bioscience AS stock

P/CF (Price-to-Cash-Flow Ratio) of Arctic Bioscience AS is -3.97 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Arctic Bioscience AS changed from -1.99 to -3.97, representing a 100.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Arctic Bioscience AS since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Arctic Bioscience AS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Arctic Bioscience AS

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Arctic Bioscience AS